These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21106879)

  • 41. Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.
    Zhang J; Chalmers MJ; Stayrook KR; Burris LL; Garcia-Ordonez RD; Pascal BD; Burris TP; Dodge JA; Griffin PR
    Structure; 2010 Oct; 18(10):1332-41. PubMed ID: 20947021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guanine nucleotide induced conformational change of Cdc42 revealed by hydrogen/deuterium exchange mass spectrometry.
    Yang SW; Ting HC; Lo YT; Wu TY; Huang HW; Yang CJ; Chan JF; Chuang MC; Hsu YH
    Biochim Biophys Acta; 2016 Jan; 1864(1):42-51. PubMed ID: 26542736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
    Yamamoto K
    Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid hormone antagonists: potential medical applications and structure activity relationships.
    Malm J; Färnegârdh M; Grover GJ; Ladenson PW
    Curr Med Chem; 2009; 16(25):3258-66. PubMed ID: 19548868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural modeling of high-affinity thyroid receptor-ligand complexes.
    de Araujo AS; Martínez L; de Paula Nicoluci R; Skaf MS; Polikarpov I
    Eur Biophys J; 2010 Oct; 39(11):1523-36. PubMed ID: 20512645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of Vitamin D Receptor Ligand-Binding Domain Regulation Studied by gREST Simulations.
    Ekimoto T; Kudo T; Yamane T; Ikeguchi M
    J Chem Inf Model; 2021 Jul; 61(7):3625-3637. PubMed ID: 34189910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications.
    Batista MR; Martínez L
    J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
    Mayer ML; Olson R; Gouaux E
    J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation.
    Selmi-Ruby S; Casanova J; Malhotra S; Roussett B; Raaka BM; Samuels HH
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):105-14. PubMed ID: 9685219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.
    Mazhab-Jafari MT; Das R; Fotheringham SA; SilDas S; Chowdhury S; Melacini G
    J Am Chem Soc; 2007 Nov; 129(46):14482-92. PubMed ID: 17973384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational Changes of Thyroid Receptors in Response to Antagonists.
    Fischer A; Frehner G; Lill MA; Smieško M
    J Chem Inf Model; 2021 Feb; 61(2):1010-1019. PubMed ID: 33449688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics.
    Anami Y; Shimizu N; Ekimoto T; Egawa D; Itoh T; Ikeguchi M; Yamamoto K
    J Med Chem; 2016 Sep; 59(17):7888-900. PubMed ID: 27535484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling.
    Duan M; Liu N; Zhou W; Li D; Yang M; Hou T
    J Chem Theory Comput; 2016 Sep; 12(9):4611-9. PubMed ID: 27560203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
    Bhat MK; McPhie P; Cheng S
    Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Region-specific anti-thyroid hormone receptor (TR) antibodies detect changes in TR structure due to ligand-binding and dimerization.
    Yen PM; Sugawara A; Forgione M; Spanjaard RA; Macchia E; Cheng SY; Chin WW
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):93-9. PubMed ID: 7511545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular dynamics simulations of ligand dissociation from thyroid hormone receptors: evidence of the likeliest escape pathway and its implications for the design of novel ligands.
    Martínez L; Webb P; Polikarpov I; Skaf MS
    J Med Chem; 2006 Jan; 49(1):23-6. PubMed ID: 16392786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.